LEE S PHARMACEUTIC.HD-05

Research LEE S PHARMACEUTIC.HD-05 (L1PA) on Bullrun: market cap EUR 67.84M, P/E 5.5, dividend yield 4.7%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerL1PA
• ExchangeF
• CountryHong Kong
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyEUR
• Market capEUR 67.84M
• P/E5.5
• Dividend yield4.7%
• Financial periodFY2025
• RevenueEUR 1.44B
• Revenue growth2.6%
• Net incomeEUR 91.94M
• Free cash flowEUR 101.35M
• Gross margin50.8%

Valuation Snapshot

latest market cap is EUR 67.84M; P/E is 5.5; dividend yield is 4.7%.

About LEE S PHARMACEUTIC.HD-05

Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments.

Frequently asked questions

What is LEE S PHARMACEUTIC.HD-05's market cap?

LEE S PHARMACEUTIC.HD-05's market capitalization is EUR 67.84M.

What is LEE S PHARMACEUTIC.HD-05's P/E ratio?

LEE S PHARMACEUTIC.HD-05's price-to-earnings (P/E) ratio is 5.5.

Does LEE S PHARMACEUTIC.HD-05 pay a dividend?

LEE S PHARMACEUTIC.HD-05 has a dividend yield of 4.7%.

What does LEE S PHARMACEUTIC.HD-05 do?

Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.